germinal center inside a lymph node
Booster Is Best in the Same Limb as Initial Vaccine: Mouse Study
Compared to mice who got the doses in separate limbs, animals receiving flu shots in the same paw for both a first and second dose had better-trained memory B cells that bound tighter to the vaccine antigen.
Booster Is Best in the Same Limb as Initial Vaccine: Mouse Study
Booster Is Best in the Same Limb as Initial Vaccine: Mouse Study

Compared to mice who got the doses in separate limbs, animals receiving flu shots in the same paw for both a first and second dose had better-trained memory B cells that bound tighter to the vaccine antigen.

Compared to mice who got the doses in separate limbs, animals receiving flu shots in the same paw for both a first and second dose had better-trained memory B cells that bound tighter to the vaccine antigen.

vaccine

Brick building with tall windows and white letters out front that say "Food and Drug Administration"
FDA Limits Use of J&J Vaccine, Citing Safety Concerns
Natalia Mesa | May 6, 2022
US adults are now only eligible for the vaccine under certain circumstances.
Baby with spotted onsie about to get injection of vaccine
Antibiotics Tied to Lower Effectiveness of Childhood Vaccines
Natalia Mesa | Apr 28, 2022
Use of the drugs in children under the age of two was associated with lower antibody levels after the jabs—perhaps, researchers suggest, due to microbiome alterations.
Discover new treatments for pandemic diseases
Treatments for Disease Pandemics
The Scientist Creative Services Team | Oct 29, 2021
Researchers develop new vaccines and therapeutics to combat the spread of infectious diseases.
Chickens in front of brown mesh coops
Bird Flu Hits US Hard
Natalia Mesa | Apr 8, 2022
So far this season, tens of millions of birds have died of disease or been culled, driving up prices of eggs, chicken, and turkey meat.
Child with head tilted back receiving oral polio vaccine
Mass Polio Vaccination Effort Underway in East Africa
Natalia Mesa | Mar 18, 2022
Malawi and its neighbors plan to vaccinate 9.4 million children against polio in the coming week to combat a suspected outbreak.
Scientific Breakthroughs with Cryogenic Electron Microscopy
The Scientist Creative Services Team, Thermo Fisher Scientific | Jun 10, 2021
Structures made via cryo-EM give researchers insights into SARS-CoV-2, HIV, neurological disorders, cancer, and more.
Vector abstract world around coronavirus macro illustration.
Living the Life Pandemic
Bob Grant | Mar 16, 2022
The first part of 2022 is giving us a glimpse of humanity’s future relationship with COVID-19.
A masked doctor in a white coat and blue gloves administers a vaccine into the arm of a masked child.
Pfizer Vaccine Less Protective for Younger Kids: Preprint
Dan Robitzski | Feb 28, 2022
The vaccine’s effectiveness in children ages 5 to 11 rapidly declined over the course of a month, according to new research that looked at the health outcomes of hundreds of thousands of children in New York during the Omicron surge.
Transforming Virology Research with Cryo-EM
The Scientist Creative Services Team, Thermo Fisher Scientific | May 11, 2021
Explore what researchers can do with Cryo-EM
Man in personal protective equipment (glasses, gloves, cap, and coat) watching plants go through a piece of machinery.
Canada Approves World’s First Plant-Based COVID-19 Vaccine
Natalia Mesa | Feb 25, 2022
Canada has ordered 76 million doses of Covifenz, the main ingredient of which was manufactured in the leaves of a tobacco relative.
People waiting in line for COVID Vaccine
CDC: COVID-19 Booster Effectiveness Wanes After Four Months
Natalia Mesa | Feb 14, 2022

The agency also finds that third shots prevented hospitalizations during the Omicron wave.


Fast-Tracking COVID-19 Research
The Scientist Creative Services Team in collaboration with Sartorius Corporation | Mar 17, 2021
Identifying molecular targets for SARS-CoV-2 therapeutics.
Photo of carved bust in front of building labeled "Institut Pasteur"
Luc Montagnier, Virologist who Codiscovered HIV, Dies at Age 89
Natalia Mesa | Feb 11, 2022
The Nobel laureate had courted controversy in recent years on vaccines and other matters.
blue gloved hand putting vial of blood into centrifuge machine
Studies Identify Risk Factors for Long COVID
Natalia Mesa | Jan 26, 2022
Two recent papers provide insight into possible risk factors for developing the chronic condition, including autoantibodies and diabetes.
T Cells: A New Hope for Lasting Protection against SARS-CoV-2
The Scientist Creative Services Team | Dec 15, 2020
Alessandro Sette and Shane Crotty discuss the T cell response to SARS-CoV-2 and the implications for vaccine design and robust immune memory.
line of people waiting outside mass vaccination site
“Nocebo” Effect May Cause Majority of COVID-19 Vaccine Symptoms
Natalia Mesa | Jan 18, 2022
A negative version of the placebo effect may be behind many instances of mild side effects associated with the jabs, a study suggests.
images related to COVID-19 pandemic, including sign reading "please keep your distance," illustration of the virus, various pills, vaccine syringes
What We Learned About COVID-19 in 2021
Shawna Williams | Dec 16, 2021
As Omicron induces a sense of deja vu at the close of the year, we look back at a few key ways in which our understanding has moved forward.
SARS-CoV-2 Antibody Durability
The Scientist Creative Services Team | Oct 2, 2020
Experts will discuss their research on SARS-CoV-2 antibody persistence and immune memory in recovered COVID-19 patients and the implications for protective immunity.
black-and-white image of an open mouth
The Common Mouth Microbe That Keeps Popping Up in Tumors
David Adam | Dec 15, 2021
Lab studies link the oral bacteria Fusobacterium nucleatum to cancers from the gut to the head and neck. Could targeting the microbe tackle tumors?